##common.pageHeaderLogo.altText##

PREVALENCE OF CHRONIC KIDNEY DISEASE AND DYSLIPIDAEMIA IN DIABETIC PATIENTS IN BUEA, SOUTH-WEST OF CAMEROON

Journal of Medical Practice and Review ,Volume 2019

Abstract

Introduction: Chronic Kidney Disease (CKD) is a major complication of diabetes worldwide. Diabetic condition can be also complicated by diabetic dyslipidemia. The prevalence of CKD Cameroon, Africa or in other parts of the world of diabetics is not clearly estimated but, some studies tried to estimate prevalences in local areas or isolated zones. In addition, assessment of both prevelances of CKD and diabetic dyslipidaemia are not well documented. The present study is aimed at estimating the prevalence of CKD and diabetic dyslipidaemia in diabetic patients in Buea, Cameroon. Methodology: This was a cross-section study conducted at the diabetic clinic of Buea Regional Hospital and the Lambe Foundation for diabetes and hypertension in Buea, South-West Region of Cameroon. Result and Discussion: Out of 120 diabetics enrolled, 63.33% were females. 53.33% were hypertensive, 74.16% overweight and obese and, 32.50% presented real obesity. The mean of eGFR was 92.76 ml/min/1.73m2 and, woman presented the lower value (89.55±43.49ml/min/1.73m2) compared to men (98.37±87.43 ml/min/1.73m2) (X2= 0.107; P = 0.466). The prevalence of CKD was 70.83% and the stage 2 was the high prevalent (36.60%). 20.83% presented CKD from stage 3 to 5. The prevalence of micro- albuminuria was 30% and macro-albuminuria was prevalent at 3.33%. Diabetic dyslipidaemia affected about half of the study population with a prevalence of 48.9%. The co-affection micro-albuminuria and diabetic dyslipidaemia was observed in 16.66% of the population individuals, against 2.50% for the co- affection macro-albuminuria and diabetic dyslipidaemia. The prevalence of diabetic dyslipidaemia among diabetic with CKD was 39.16% (X2=0.118).


Conclusion: This study shown the high prevalence of CKD in diabetics and, was the first to assess the


prevalences of both CKD and diabetic dyslipidaemia in diabetic Cameroonians. The findings advice on the assessment of the complications of diabetes in Cameroon in order to estimate, in more large population, risk factors and pattern of diabetic dyslipidaemia and CKD in diabetic Cameroonian.

Keywords:
  • CKD, diabetic dyslipidaemia, diabetes, Cameroon, Prevalence

How to Cite

Mbarawa Marat Kofia Ibrahim. (2019). PREVALENCE OF CHRONIC KIDNEY DISEASE AND DYSLIPIDAEMIA IN DIABETIC PATIENTS IN BUEA, SOUTH-WEST OF CAMEROON. Journal of Medical Practice and Review. Retrieved from https://everant.in/index.php/jmpr/article/view/13

Download Citation

References

  • Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL and Eckardt KU.The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17–28
  • ] Kaneto H, Naoto K, Munehide M and Taka- aki M. Role of Reactive Oxygen Species in the Progression of Type 2 Diabetes and Atherosclerosis. Mediators Inflammation. 2010; 453892:1-11
  • ] Ayodele OE, Alebiosu CO and Salako BL. Diabetic nephropathy: A review of the natural history, burden, risk factors and treatment. J Natl Med Assoc, 2004, 96: 1445-1454.
  • ] Zelmanovitz T, Fernando GF, Balthazar APS, Thomazelli FCS, Matos JD and Canani LH. Diabetic nephropathy. Diab Metab Synd, 2009, 1:10-17
  • ] Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE. Functional and structural changes in the kidney in the early stages of obesity. J Am SocNephrol, 2001, 12: 1211-
  • ] Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y, J Am SocNephrol, 2003, 14:1480-1486.
  • ] American Diabetes Association. Standards of medical care in diabetes-2011, Diabetes Care,2011, 34: S11-61
  • ] National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-421.
  • ] Taskinen MR. Diabetic dyslipidemia.
  • Atheroscler. 2002; 3: 47–51
  • ] Folli F, Corradi D, Fanti P, Davalli A, Paez
  • A, et al. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr Diabetes Rev . 2011;7: 313– 324.
  • ] Maritim AC, Sanders RA, Watkins JB. Diabetes, oxidative stress,and antioxidants: a review. J Biochem Mol Toxicol. 2003; 17: 24–38.
  • ] Noubiap JJN, Naidoo J and Kengne AP. Diabetic nephropathy in Africa: A systematic review. 20015. World J Diabetes. 2015. 10;6(5):759-773
  • ] Sobngwi E, Mbanya JC, Moukouri EN and Ngu KB. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract. 1999 Jun;44(3):191-196
  • ] Choukem SP, Dzudie A, Dehayem M, Halle MP, Doualla MS, Luma H, Kengne AP. Comparison of different blood pressure indices for the prediction of prevalent diabetic nephropathy in a sub-Saharan African population with type 2 diabetes. Pan Afr Med J 2012; 11: 67
  • ] Agoons DD, Balti EV, Kaze FF, Azabji- Kenfack M, Ashungtantang G, Kegne AP, Sobngwi E and Mbanya JC. Performance of three glomerular filtration rate estimation equations in a population of sub-Saharan Africans with Type 2 diabetes. Diabet Med. 2016: 33(9)-1291-1298
  • ] Bissong MEA, Teke GN, Sanje M, Goneh H, Foka FET and Kamga HL. Microalbuminuria in Diabetic Patients in the Bamenda Health District. Science Journal of Clinical Medicine. 2017; 6(4):63-67
  • ] Tamba SM, Ewane ME, Bonny A, Muisi CN, Nana E, Ellong A, Mvogo CE and Mandengue SH. Micro and macrovascular complications of diabetes mellitus in Cameroon: risk factors and effect of diabetic check-up - a monocentric observational study. Pan African Medical J. 2013; 15:141
  • ] Kamguia L, Dehayem MY, Sonafouo DVF, Kenmegne AB, Endomba FTA, Tankeu AT, Matip MAN, Sobngwi E and Mbanya JC. Atteinte rénale et facteurs associés chez les patients jeunes vivant avec le diabète de type 1 au Cameroun. Congres annuel societe francophone du diabete 2018. Nante, 2018.
  • EP126
  • ] Njikam EJ, Kariuki MM, Kollmann MKH, Wilhelm F and Nentwich MM. The magnitude and pattern of diabetic retinopathy in Yaound e, Cameroon – a cross-sectional hospitalbased study. Acta Ophthalmologica. 2016;94(2):e156-e157
  • ] Vitalis FF, Choukem SP, Kengne AP, Nebongo DN and Ngowe-Ngowe M. Anemia in type 2 diabetic patients and correlation with kidney function in a tertiary care sub-Saharan African hospital: a cross- sectional study. BMC Nephrol. 2016; 17:
  • -35
  • ] WHO. Physical status: the use and interpretation of anthropometry. WHO. http://www.who.int/childgrowth/publication s/physical_status/en/.Accessed the 24thNovember 2017.
  • ] Muntner P, Bowling BC, Shimbo D. Systolic blood pressure goals to reduce cardiovascular disease among older adults. Am J Med Sci. 2014; 348(2): 129–134.
  • ] American Diabetes Association. Standards of Medical Care in Diabetes: Glycemic targets. Diabetes Care. 2017; 40 (Suppl. 1):
  • S48-S56
  • ] Bouenizabila E, Loumingou R, Motoula M, Andzouana N and Monabeka HG. Diabetic nephropathy at Brazzaville University Hospital, Congo: Epidemiological and clinical aspects, and risk factors. Méd maladies Mét. 2015; 9(2):220-226
  • ] Hamat I, Mahamat GA, Cisse MM, Youssouf M, Saboune M, Djafar, Mbainguinam D and Fotclossou T. Profile of diabetic nephropathy at the National Reference General Hospital of N'Djamena (Chad) The Pan African Medical Journal. 2016; 24:193
  • ] Tauseef A, Ulhaq I, Mawani M and Islam N. Microalbuminuria in type 2 diabetes Mellitus; the tip of iceberg of diabetic complications. Pak J Med Sci. 2017; 33(3):519-523
  • ] AlFehaid AA. Prevalence of microalbuminuria and its correlates among diabetic patients attending diabetic clinic at National Guard Hospital in Alhasa. J Fam Community Med. 2017:24:1-5
  • ] Khadka B, Tiwari ML, Risal P, Gupta S and Acharya D. Prevalence and factors associated with microalbuminuria among type 2 diabetic patients: A hospital based study. J Nepal Med Assoc. 2018;56(209):516-521
  • ] Kasia BE and Idogum SE. Prevalence of microalbuminuria and its risk factors in type
  • diabetes patients. Annals Biomedical Sciences. 2018; 17(2):37-44
  • ] Rissassi JRM, Nseka NM, Jadoul M, Lipira FB, Mvitu M, Mbenza G, Yekoladio D, Aloni M and Nge OO. Prevalence and determinantsof microalbuminuria and macroalbuminuria in children and young adults with type 1 diabetes in Kinshasa.
  • Nephro Therapeutique. 2009; 6(1)40-46
  • ] Mohan MM and Sekhar CV. Prevalence and risk factors of microalbuminuria in type 2 diabetes mellitus. Int J Adv Med. 2015; 2(4):383-386
    • Article Viewed: 56 Total Download

    ##plugins.themes.ojsPlusA.frontend.article.downloadstatastics##

    Make a Submission

    Make a Submission

    Information